Fig. 3From: Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisRisk of the first recurrence between days 7 and 90 in patients with adherence by total mg/kg dose administered. The shaded areas represent 95% CIsBack to article page